BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 20, 2006
View Archived Issues
RF9: the first neuropeptide FF antagonist prevents opioid tolerance
Read More
ChemGenex and Merck KGaA sign new three-year alliance agreement
Read More
Series A financing at CoLucid Pharmaceuticals
Read More
ImmuneRegen BioSciences submits proposal to Department of Defense
Read More
Targeting cannabinoid CB2 for bone protection
Read More
PPARgamma activation suppresses BACE1 to reduce AD pathophysiology
Read More
BioLineRx inlicenses new compounds, updates pipeline progress
Read More
Positive toxicology data for Binoxan active ingredient
Read More
AlphaVax and Wyeth enhance partnership
Read More
Ligand and Organon terminate Avinza copromotion
Read More
Boehringer Ingelheim launches RE-VOLUTION program for dabigatran etexilate
Read More
IND submission for clinical trials of Myodur in Duchenne muscular dystrophy
Read More
New German study evaluates AM-111 in acute sensorineural hearing loss
Read More
sanofi-aventis transfers Exubera rights to Pfizer
Read More
FDA requests pediatric studies of zolpidem
Read More
New Aphios subsidiary to develop antiinfluenza drugs from marine microorganisms
Read More
Caprion and Icos form new biomarker research collaboration
Read More
Ablynx signs Nanobodies collaboration agreement with Novartis
Read More
Novel agents for diabetes reported in recent patent literature
Read More
Recent patents describe novel agents for metabolic disorders
Read More
Novel therapeutics for neurological disorders reported in recent patent literature
Read More
Recent patent discloses novel therapeutic agents for ocular disorders
Read More
Continuous antiretroviral therapy found superior to episodic therapy
Read More
Data made available on 3G4, mouse equivalent of Tarvacin, in models of pancreatic cancer
Read More
alphaB-Crystallin proposed as a novel oncoprotein
Read More
